7,622.95

+42.88

+0.57%

52,281.12

+510.81

+0.99%

25,613.33

+176.33

+0.69%

2,837.17

+25.32

+0.90%

4.8800

-0.0490

-0.99%

18.89

-0.53

-2.73%

3,974.10

+75.20

+1.93%

77,344.33

-675.67

-0.87%

Crude Oil Dec 26

97.06

-7.06

-6.78%

US Private Equity

10,850.63

-82.20

-0.75%

Toronto - Free Realtime Quote CAD

WELL Health Technologies Corp. (WELL.TO)

4.2600 +0.0800 (+1.91%)

As of 11:38:43 AM EST. Market Open.

Loading Chart for WELL.TO

Chart Range Bar

Interval:

In partnership with ChartIQ

WELL Health to Announce Third Quarter 2026 Financial Results on November 9, 2026

WELL Health to Announce Third Quarter 2026 Financial Results on November 9, 2026

WELL Health and HEALWELL Announce Competition Bureau Has Concluded Its Merger Review and Issued a No Action Letter

WELL Health and HEALWELL Announce Competition Bureau Has Concluded Its Merger Review and Issued a No Action Letter

HEALWELL and WELL Health Announce Competition Bureau has Concluded Its Merger Review and Issued a No Action Letter

HEALWELL and WELL Health Announce Competition Bureau has Concluded Its Merger Review and Issued a No Action Letter

WELL Health Strengthens Privacy and AI Governance Leadership with Appointment of Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory

WELL Health Strengthens Privacy and AI Governance Leadership with Appointment of Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory

WELL Health to Present at The Cantech Investment Conference on October 8 in Toronto

WELL Health Subsidiary WELLSTAR Announces Completion of Amalgamation and Expected Trading Date of

WELL Health Subsidiary WELLSTAR Announces Completion of Amalgamation and Expected Trading Date of "WSTR" on TSXV

WELL Health Subsidiary WELLSTAR Announces Conditional Approval for TSXV Listing and Files Filing Statement

WELL Health Subsidiary WELLSTAR Announces Conditional Approval for TSXV Listing and Files Filing Statement

WELL Health Launches WELL Research, an End-to-End Clinical Trial Platform Built on Canada's Largest Outpatient Network

WELL Health Launches WELL Research, an End-to-End Clinical Trial Platform Built on Canada's Largest Outpatient Network

WELL Health Announces Planned CFO Transition; Evelyn Sutherland Appointed Chief Financial Officer

WELL Health Announces Planned CFO Transition; Evelyn Sutherland Appointed Chief Financial Officer

WELL Health Redeems $70 Million 5.50% Convertible Debentures

WELL Health Redeems $70 Million 5.50% Convertible Debentures

WELL Health Technologies Q2 Earnings Call Highlights

WELL Health Technologies Q2 Earnings Call Highlights

Mobilize your Website

View Site in Mobile | Classic

Share by: